Veterinary Medicines

NIMATEK 100 mg/ml, Solution for injection for dogs, cats and horses

Authorised
  • Ketamine hydrochloride
Download as PDF

Product identification

Medicine name:
NIMATEK 100 mg/ml, Solution for injection for dogs, cats and horses
Nimatek Vet. 100 mg/ml Injektionsvätska, lösning
Active substance:
  • Ketamine hydrochloride
Target species:
  • Dog
  • Cat
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Ketamine hydrochloride
    115.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Horse
      • Meat and offal
        1
        day
      • Milk
        1
        day
    • Cat
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Package description:
  • Clear colourless type I glass vial with bromobutyl rubber stopper and aluminium cap filled with 5 ml.1 vial in a cardboard box.
  • Clear colourless type I glass vial with bromobutyl rubber stopper and aluminium cap filled with 10 ml.1 vial in a cardboard box.
  • Clear colourless type I glass vial with bromobutyl rubber stopper and aluminium cap filled with 20 ml.1 vial in a cardboard box.
  • Clear colourless type I glass vial with bromobutyl rubber stopper and aluminium cap filled with 25 ml.1 vial in a cardboard box.
  • Clear colourless type I glass vial with bromobutyl rubber stopper and aluminium cap filled with 30 ml.1 vial in a cardboard box.
  • Clear colourless type I glass vial with bromobutyl rubber stopper and aluminium cap filled with 50 ml.1 vial in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Eurovet Animal Health B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 49564
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0475/001
Concerned member states:
  • Austria
  • Finland
  • Italy
  • Poland
  • Portugal
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
Swedish (PDF)
Published on: 9/06/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 9/06/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 21/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."